Alzheimer's Disease Clinical Trials in Los Angeles

Showing 121-140 of 175 trials

Depression in Alzheimer's Disease-2

NCT00086138

The purpose of this study is to learn whether treating individuals with Alzheimer's disease and depression with the anti-depressant medication sertraline (Zoloft) is helpful to people with Alzheimer's disease and to their families and caregivers.

Alzheimer's DiseaseDepression

Johns Hopkins University131 participantsStarted Jul 2004

Los Angeles, California, United States • Baltimore, Maryland, United States • Rochester, New York, United States +2 more locations

COMPLETED< 1 mile

ADNI: Alzheimer's Disease Neuroimaging Initiative

NCT00106899

The purpose of this study is to examine how brain imaging technology can be used with other tests to measure the progression of mild cognitive impairment (MCI) and early Alzheimer's disease (AD). This information will aid future clinical trials by providing a standard assessment tool to measure the effects of treatments being studied.

Alzheimer's Disease

Alzheimer's Disease Cooperative Study (ADCS)818 participantsStarted Jul 2005

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Sun City, Arizona, United States +56 more locations

Depression in Alzheimer's Disease-2

ADNI: Alzheimer's Disease Neuroimaging Initiative

Alzheimer's Disease Trials in Other Cities

Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025

Evaluating Cerebrospinal Fluid Biomarkers in Alzheimer's, Progressive Supranuclear Palsy Subjects, and Controls

Online Caregiver Psychoeducation and Support for Alzheimer's

A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease Therapy

Open-label Study of Flexible-dose Paliperidone ER (Extended Release) to Treat Adolescent Schizophrenia.

Evaluate the Efficacy and Safety of ABT-126 in Subjects With Mild to Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase Inhibitors

Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose)

Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

Safety and Cognitive Function Study of EVP-6124 in Patients With Mild to Moderate Alzheimer's Disease

Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

Effect of NeuroAD on the Cognitive Function of Alzheimer Patients

PRISM Registry: Pseudobulbar Affect Registry Series

Coordinating Center for Caregiver Intervention Trial

A Long Term Extension Study Evaluating ACC-001 With QS-21 in Subjects With Mild to Moderate Alzheimer's Disease

Study Evaluating ACC-001 In Subjects With Mild To Moderate Alzheimer's Disease

A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease

Efficacy Study of a ZT-1 Implant in Patients Suffering From Alzheimer's Disease

Other Conditions in Los Angeles